Baldeep Kumar1, Anurag Kuhad, Kanwaljit Chopra. 1. Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Study, Panjab University, Chandigarh, 160014, India.
Abstract
RATIONALE: A complex relationship exists among stressful situations, body's reaction to stress, and the onset of clinical depression. Chronic unpredictable stressors can produce a situation similar to clinical depression, and such animal models can be used for the preclinical evaluation of antidepressants. Many findings have shown that the levels of proinflammatory cytokines (e.g., TNF-α) and oxidative stress (increased lipid peroxidation, decreased glutathione levels, and endogenous antioxidant enzyme activities) are increased in patients with depression. Sesamol, a phenolic derivative with a methylenedioxy group, is a potent inhibitor of cytokine production as well as an antioxidant. OBJECTIVES: The present study was designed to investigate the effect of sesamol on unpredictable chronic stress-induced behavioral and biochemical alterations in mice. METHODS: Animals were subjected to different stress paradigms daily for a period of 21 days to induce depressive-like behavior. The sucrose preference, immobility period, locomotor activity, memory acquisition, and retention were evaluated. RESULTS: Chronic treatment with sesamol significantly reversed the unpredictable chronic stress-induced behavioral (increased immobility period, reduced sucrose preference), biochemical (increased lipid peroxidation and nitrite levels; decreased glutathione levels, superoxide dismutase and catalase activities), and inflammation surge (serum TNF-α) in stressed mice. CONCLUSION: The study revealed that sesamol exerted antidepressant-like effects in behavioral despair paradigm in chronically stressed mice, specifically by modulating central oxidative-nitrosative stress and inflammation.
RATIONALE: A complex relationship exists among stressful situations, body's reaction to stress, and the onset of clinical depression. Chronic unpredictable stressors can produce a situation similar to clinical depression, and such animal models can be used for the preclinical evaluation of antidepressants. Many findings have shown that the levels of proinflammatory cytokines (e.g., TNF-α) and oxidative stress (increased lipid peroxidation, decreased glutathione levels, and endogenous antioxidant enzyme activities) are increased in patients with depression. Sesamol, a phenolic derivative with a methylenedioxy group, is a potent inhibitor of cytokine production as well as an antioxidant. OBJECTIVES: The present study was designed to investigate the effect of sesamol on unpredictable chronic stress-induced behavioral and biochemical alterations in mice. METHODS: Animals were subjected to different stress paradigms daily for a period of 21 days to induce depressive-like behavior. The sucrose preference, immobility period, locomotor activity, memory acquisition, and retention were evaluated. RESULTS: Chronic treatment with sesamol significantly reversed the unpredictable chronic stress-induced behavioral (increased immobility period, reduced sucrose preference), biochemical (increased lipid peroxidation and nitrite levels; decreased glutathione levels, superoxide dismutase and catalase activities), and inflammation surge (serum TNF-α) in stressed mice. CONCLUSION: The study revealed that sesamol exerted antidepressant-like effects in behavioral despair paradigm in chronically stressed mice, specifically by modulating central oxidative-nitrosative stress and inflammation.
Authors: Vipan Kumar Parihar; K R Prabhakar; Veeresh P Veerapur; M Sudheer Kumar; Y Rosi Reddy; Ravi Joshi; M K Unnikrishnan; C Mallikarjuna Rao Journal: Mutat Res Date: 2006-10-11 Impact factor: 2.433
Authors: C R Yang; Y Y Bai; C S Ruan; H F Zhou; D Liu; X F Wang; L J Shen; H Y Zheng; X F Zhou Journal: Neurotox Res Date: 2014-11-04 Impact factor: 3.911
Authors: Sho Moriguchi; Alan A Wilson; Laura Miler; Pablo M Rusjan; Neil Vasdev; Stephen J Kish; Grazyna Rajkowska; Junming Wang; Michael Bagby; Romina Mizrahi; Ben Varughese; Sylvain Houle; Jeffrey H Meyer Journal: JAMA Psychiatry Date: 2019-06-01 Impact factor: 21.596
Authors: Ronise M Santiago; Janaína Barbiero; Bruno J Martynhak; Suelen L Boschen; Luisa M da Silva; Maria F P Werner; Claudio Da Cunha; Roberto Andreatini; Marcelo M S Lima; Maria A B F Vital Journal: J Neural Transm (Vienna) Date: 2014-01-24 Impact factor: 3.575
Authors: Luana M Manosso; Morgana Moretti; André R Colla; Camille M Ribeiro; Tharine Dal-Cim; Carla I Tasca; Ana Lúcia S Rodrigues Journal: J Neural Transm (Vienna) Date: 2016-01-08 Impact factor: 3.575
Authors: C R Yang; Z G Zhang; Y Y Bai; H Fiona Zhou; L Zhou; C S Ruan; F Li; C Q Li; H Y Zheng; L J Shen; X F Zhou Journal: Neurotox Res Date: 2013-07-20 Impact factor: 3.911